[Retracted] Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis

<div>Comparison of treatment effects between the two groups The observation group had 6 cases of CR, 28 cases of PR, 8 cases of SD, and 1 case of PD, with a total remission rate of 97.67%; the control group had 3 cases of CR, 22 cases of PR, 18 cases of SD, and 10 cases of PD, and the total response rate was 97.67%. The remission rate was 81.13%.</div>

Computational and Mathematical Methods in Medicine

fig1

Figure 1

Figure 1: [Retracted] Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis 

Figure 1 | [Retracted] Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis 